Wave Life Sciences (WVE) Operating Margin (2016 - 2025)
Historic Operating Margin for Wave Life Sciences (WVE) over the last 11 years, with Q2 2025 value amounting to 606.49%.
- Wave Life Sciences' Operating Margin fell 4287700.0% to 606.49% in Q2 2025 from the same period last year, while for Sep 2025 it was 760.6%, marking a year-over-year decrease of 5124900.0%. This contributed to the annual value of 101.94% for FY2024, which is 419300.0% down from last year.
- According to the latest figures from Q2 2025, Wave Life Sciences' Operating Margin is 606.49%, which was down 4287700.0% from 542.82% recorded in Q1 2025.
- Wave Life Sciences' 5-year Operating Margin high stood at 9.03% for Q3 2023, and its period low was 13648.77% during Q3 2022.
- Its 5-year average for Operating Margin is 2405.62%, with a median of 542.82% in 2025.
- As far as peak fluctuations go, Wave Life Sciences' Operating Margin crashed by -136278900bps in 2022, and later soared by 136578000bps in 2023.
- Wave Life Sciences' Operating Margin (Quarter) stood at 2045.89% in 2021, then tumbled by -72bps to 3515.98% in 2022, then soared by 98bps to 64.3% in 2023, then plummeted by -176bps to 177.72% in 2024, then tumbled by -241bps to 606.49% in 2025.
- Its Operating Margin stands at 606.49% for Q2 2025, versus 542.82% for Q1 2025 and 177.72% for Q2 2024.